R
Rxilient Health
Providing competitive healthcare solutions for unmet needs
About Rxilient Health
Rxilient Health is an open platform enterprise dedicated to linking pharmaceutical innovation with commercialization. The company focuses on improving disease care and clinical practices to benefit patients. Rxilient Health operates in the medical, health, and beauty sectors, providing competitive products and services to meet unmet clinical needs. The company builds a professional product matrix in dermatology and medical aesthetics, aiming to fulfill diverse skin health and aesthetic needs with a scientific mindset. Additionally, Rxilient Health identifies, develops, and commercializes urgently needed ophthalmic medicines and devices to enhance disease diagnosis and treatment, driving biotechnology breakthroughs in ophthalmology. In oncology, the company stringently selects global consumer health products to improve patient outcomes. Rxilient Health serves a broad range of clients, including healthcare providers, medical professionals, and patients, operating primarily in the pharmaceutical and medical device markets. The business model revolves around the development, commercialization, and lifecycle management of innovative medical products. Revenue is generated through the sale of these products and services, as well as through strategic partnerships and collaborations within the medical innovation ecosystem.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Singapore, Singapore
- Employees
- 38
- Open positions
- 3
- Dealroom signal
- 55.5/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Hard Tech
- Client focus
- b2b, b2c
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Oct 2023 | $30M | $120M | Legend Capital · Pharmaron Holding · China Medical System Holdings | ↗ |
Growth signals
Latest recorded traffic for Rxilient Health is 5.5K monthly website visits, up 189.5% over the last three months. Rxilient Health's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Legend Capital
Pharmaron Holding
China Medical System Holdings
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Rxilient Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Rxilient Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.